This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides FDA Peptide Reclassification 2026: What It Means for Providers FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of BULK DRUG SUBSTANCES AND FDA EVALUATION Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health